Cargando…
Risk of Bacteriophage Therapeutics to Transfer Genetic Material and Contain Contaminants Beyond Endotoxins with Clinically Relevant Mitigation Strategies
Bacteriophage therapy is a promising adjuvant therapeutic in the treatment of multidrug-resistant infections and chronic biofilm infections. However, there is limited knowledge about how to best utilize these agents in vivo, leading to a wide range of treatment protocols. Moreover, while bacteriopha...
Autor principal: | Doub, James B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711558/ https://www.ncbi.nlm.nih.gov/pubmed/34992389 http://dx.doi.org/10.2147/IDR.S341265 |
Ejemplares similares
-
Bacteriophage Therapy for Clinical Biofilm Infections: Parameters That Influence Treatment Protocols and Current Treatment Approaches
por: Doub, James B.
Publicado: (2020) -
Potential Use of Adjuvant Bacteriophage Therapy With Debridement, Antibiotics, and Implant Retention Surgery to Treat Chronic Prosthetic Joint Infections
por: Doub, James B, et al.
Publicado: (2021) -
The role of endotoxin in septic shock
por: Kellum, John A., et al.
Publicado: (2023) -
COVID-19 in India: Moving from containment to mitigation
por: Varghese, George M., et al.
Publicado: (2020) -
Synthetic biology regulation in Europe: containment, release and beyond
por: Sundaram, Lalitha S, et al.
Publicado: (2023)